investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
IKK <alpha> and the Control of Prostate Cancer Metastasis
Michael Karin
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Karin
University of California, San Diego
San Diego, United States
Maarten Van Lohuizen
Netherlands Cancer Institute
Amsterdam, Netherlands
Related projects
William Figg
Clinical Pharmacogenetics
Prostate
Pathology
Anne E Cress
Human Prostate Cancer Metastasis and Laminin Binding Integrins
Prostate
Pathology
Stefan Ambs
The Molecular Profile of Prostate Tumors in African-American Men
Prostate
Pathology
William Figg
Development of Drugs that Target Prostate Cancer
Prostate
Pathology
Philip A Beachy
Epithelial/stromal signaling in bladder and prostate cell proliferation
Prostate
Pathology
Hui-Kuan Lin
The Crosstalk Between the PI3K/Akt signal and Skp2 in Prostate Cancer Progression
Prostate
Pathology
Radoslav Goldman
Basic Cancer Research in Cancer Health Disparities
Prostate
Pathology
William Figg
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
Prostate
Pathology
Zijie Sun
A New Regulator for Wnt/beta-catenin Signaling and Prostate Tumorigenesis
Prostate
Pathology
